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Abstract
Background: The ATP-binding cassette transporter ABCC6 gene is located on chromosome 16 between its two
pseudogenes (ABCC6P1 and ABCC6P2). Previously, we have shown that ABCC6P1 is transcribed and affects ABCC6 at
the transcriptional level. In this study we aimed to determine copy number variations of ABCC6, ABCC6P1 and
ABCC6P2 in different populations. Moreover, we sought to study the transcription pattern of ABCC6 and ABCC6
pseudogenes in 39 different human tissues.
Findings: Genomic DNA from healthy individuals from five populations, Chinese (n = 24), Middle East (n = 20),
Mexicans (n = 24), Caucasians (n = 50) and Africans (n = 24), were examined for copy number variations of ABCC6
and its pseudogenes by pyrosequencing and quantitative PCR. Copy number variation of ABCC6 was very rare
(2/142; 1.4%). However, one or three copies of ABCC6P1 were relatively common (3% and 8%, respectively). Only one
person had a single copy of ABCC6P2 while none had three copies. In Chinese, deletions or duplications of ABCC6P1
were more frequent than in any other population (9/24; 37.5%). The transcription pattern of ABCC6P2 was highly
similar to ABCC6 and ABCC6P1, with highest transcription in liver and kidney. Interestingly, the total transcription level
of pseudogenes, ABCC6P1+ ABCC6P2, was higher than ABCC6 in most tissues, including liver and kidney.
Conclusions: Copy number variations of the ABCC6 pseudogenes are quite common, especially in populations of
Chinese ancestry. The expression pattern of ABCC6P2 in 39 human tissues was highly similar to that of ABCC6 and
ABCC6P1 suggesting similar regulatory mechanisms for ABCC6 and its pseudogenes.
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Findings
Background
The ATP-binding cassette transporter ABCC6 belongs
to a large family of membrane proteins (ABC transpor-
ters) that are a highly conserved and present in all
organisms from bacteria to man [1,2]. The ABCC6 gene
(Entrez Gene ID 368) is located on the short arm of
chromosome 16 along with two shorter, almost identical
(> 99% sequence identity), pseudogenes; ABCC6P1
(Entrez Gene ID 653190) and ABCC6P2 (Entrez Gene
ID 730013) (Figure 1) [3]. Pseudogenes are generally
defined as non-functional genes, meaning that they usu-
ally do not produce a transcript or a functional protein
[4,5]. Transcription of ABCC6 pseudogenes have been
described [3,6,7], and recently we found strong evidence
for a regulatory interdependency between ABCC6 and
its pseudogene ABCC6P1 [7].
Mutations and deletions in ABCC6 are known to cause
the rare (prevalence between 1:25,000 and 1:100,000),
autosomal recessive disease pseudoxanthoma elasticum
(PXE, OMIM 264800), a metabolic disorder character-
ized by ectopic mineralization of soft connective tissues
[8,9]. ABCC6 is located on chromosome 16, a known
hotspot of chromosomal instability, showing several gen-
omic duplications and deletions (generally called copy
number variations) [10,11]. We therefore hypothesized
that ABCC6 pseudogenes would be liable to chromo-
somal rearrangements and thereby subject to copy num-
ber variations. Having less or more copies of ABCC6
pseudogenes is likely to influence the expression level of
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these pseudogenes, and thus, may have an impact on the
parent gene ABCC6, including the genetic message, the
protein level and the function of the protein.
Estimation of copy number variations and transcrip-
tion of pseudogenes is generally difficult because of the
high sequence similarity between pseudogenes and their
parent genes. However, pyrosequencing has recently
shown to be a helpful tool to differentiate between
highly similar genes by only one nucleotide difference
[12]. Therefore, principally by the use of pyrosequencing,
the aim of this study was to determine copy number var-
iations of ABCC6, ABCC6P1 and ABCC6P2. Moreover,
we sought to study the mRNA transcription pattern of
ABCC6, ABCC6P1 and ABCC6P2 in 39 different human
tissues.
Results
Copy number variations in ABCC6 and its pseudogenes in
human samples
Copy number variation of ABCC6 was very rare (2/142;
1.4%) (Table 1) in healthy individuals. No individuals
had deletions of ABCC6. Deviation in copy number was
more frequent for ABCC6 pseudogenes. In Chinese,
deletions or duplications of ABCC6P1 were more
frequent than in any other population (9/24; 37.5%). Fur-
thermore, in the total population (n = 142), one or three
copies of ABCC6P1 was relatively common (3% and 8%,
respectively). Only one person had one copy of
ABCC6P2 while none had three copies. In Africans,
however, no copy number variation was found for
ABCC6 pseudogenes. All the members of two Centre
d’Etude du Polymorphisme Humain (CEPH) pedigrees
had two copies of ABCC6, ABCC6P1 and ABCC6P2
(data not shown). As copy number variation was ana-
lyzed in short specific regions of ABCC6 and ABCC6
pseudogenes, small deletions/insertions in other regions
of these genes cannot be excluded.
Gene expression of ABCC6 and its pseudogenes in human
samples
ABCC6 and ABCC6 pseudogene expression profiling
was performed in various human tissues (not corre-
sponding to individuals analyzed for copy number varia-
tions). The transcription pattern of ABCC6P2 was highly
similar to ABCC6 and ABCC6P1, with highest transcrip-
tion in liver and kidney (Figure 2 A-C). Interestingly, the
total mRNA level of ABCC6 pseudogenes, ABCC6P1+
ABCC6P2, was higher than ABCC6 mRNA levels in
A GGC T
ABCC6P1ABCC6ABCC6P2
(+1.3Mb) (+2.3Mb)
2 Kb
Figure 1 Genomic organization of ABCC6, ABCC6P1 and ABCC6P2. ABCC6 is located on chromosome 16p13 between its two pseudogenes,
ABCC6P1 and ABCC6P2, at a distance of 2.3 Mb and 1.3 Mb, respectively. The boxes indicate the size of the genes and the arrows indicate the
direction for transcription. Nucleotide difference in exon 2 between ABCC6 (G), ABCC6P1 (G) and ABCC6P2 (A) is indicated in red colour while
nucleotide difference in intron 7 between ABCC6 (C) and ABCC6P1 (T) is indicated in orange colour.
Table 1 Copy number variation in different populations
Genes Copies Caucasians
(N= 50)
Mexicans
(N= 24)
Middle-East
(N= 20)
Africans
(N =24)
Chinese
(N = 24)
Total
(N= 142)
N (%) N (%) N (%) N (%) N (%) N (%)
ABCC6 1 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
2 50 (100) 23 (96) 20 (100) 24 (100) 23 (96) 140 (99)
3 0 (0) 1 (4) 0 (0) 0 (0) 1 (4) 2 (1)
ABCC6P1 1 0 (0) 0 (0) 1 (5) 0 (0) 4 (17) 5 (3)
2 47 (94) 23 (96) 17 (85) 24 (100) 15 (62) 126 (89)
3 3 (6) 1 (4) 2 (10) 0 (0) 5 (21) 11 (8)
ABCC6P2 1 0 (0) 0 (0) 0 (0) 0 (0) 1 (4) 1 (1)
2 50 (100) 24 (100) 20 (100) 24 (100) 23 (96) 141 (99)
3 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
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Figure 2 mRNA expression of ABCC6 and its pseudogenes ABCC6P1 and ABCC6P2 in a variety of human tissues. Relative normalized
transcription of ABCC6 (A), ABCC6P1 (B) and ABCC6P2 (C) in 39 human tissues. The tissue with the highest expression (liver pool) was used as
reference tissue (100%). (D) Expression of ABCC6 relative to ABCC6P1 and ABCC6P2. Ratios are shown as a logarithmic scale (base 2).
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most tissues, including liver and kidney (Figure 2 D).
However, it should be noted that in tissues with low
ABCC6 mRNA levels, differences in expression between
ABCC6 and its pseudogenes may result from stochastic
effects during the PCR.
Discussion
In this study, we found copy number variation of
ABCC6 pseudogenes to be frequent, especially in popu-
lations of Chinese ancestry. However, as expected in
healthy populations, no individuals had deletions of
ABCC6. ABCC6 and its pseudogenes, with their high se-
quence identity (>99%), represent a low copy repeat
(LCR). LCRs are paralogue segments of usually >10 kb
with >97% sequence identity and can act as substrates
for nonallelic homologous recombination which may
lead to deletion, duplication or inversion of the interven-
ing sequence [13,14]. Phylogenetic trees on human and
chimpanzee sequences show that ABCC6 pseudogenes
have occurred independently several times in these spe-
cies, which further demonstrate the high mobility of
these genes [15]. Our results confirm the hypothesis that
ABCC6 pseudogenes would be liable to genomic in-
stability and thereby copy number variations.
Six percent of Caucasians are expected to have three
copies of ABCC6P1 (Table 1). However, none of the 35
members of two 3-generation-pedigrees (CEPH pedi-
grees) had deviation from the normal copy of two of
ABCC6 or ABCC6 pseudogenes, indicating a Mendelian
transmission of these copy numbers and that de novo
deletion/duplication of pseudogenes do not arise
frequently.
ABCC6 and its pseudogenes share highly similar prox-
imal promoter sequences (> 98.5% sequence identity)
[7]. Furthermore, the hepatocyte nuclear factor 4α
(HNF4α) binding site located at −166/-154 of the
ABCC6 promoter, which is crucial for tissue-specific ex-
pression pattern of ABCC6 [16,17], is also present in the
ABCC6P1 and ABCC6P2 promoters. Thus, the finding
of similar expression pattern for ABCC6 and both pseu-
dogenes in human tissues strongly imply similar regula-
tory mechanisms for ABCC6 and its pseudogenes. On
the other hand, these results also suggest that both
ABCC6- and ABCC6 pseudogene transcripts have simi-
lar half-lives, which is surprising since they do not share
the same mRNA 3’-ends. Pseudogenes were for a long
time assumed to be “junk DNA”. However, recent stud-
ies have shown that many pseudogenes are functionally
active and that they may influence their parent gene
[7,18-23], and potential mechanisms of pseudogene
function have been suggested. Copy number variation in
pseudogenes has previously also been identified for the
Neutrophil cytosolic factor 1 (NCF1) pseudogenes [24-
26]. NCF1 is a component of NADPH oxidase and
having fewer or more copies of NCF1 pseudogenes seem
to influence the production of reactive oxygen inter-
mediates [24,26]. It would therefore be interesting to in-
vestigate whether different copy numbers of ABCC6
pseudogenes also influences the expression of the
ABCC6 gene. Unfortunately, the expression of ABCC6,
ABCC6P1 and ABCC6P2 in various human lymphoblas-
toid cell lines with one, two or three copies of ABCC6P1,
which could be used for these studies, was too low to be
detected by reverse transcription - quantitative real-time
PCR (RT-qPCR) or pyrosequencing (data not shown).
Methods
Human samples
Genomic DNA from the National Institute of General
Medical Science (NIGMS) Human Variation Panels was
purchased from the Coriell Cell Repositories (Camden,
USA): The Caucasian Panel (n = 50); The Han People of
Los Angeles Panel (n = 24); The Middle Eastern Panel,
version 1 and 2, (n = 20); The Mexican-American Com-
munity of Los Angeles Panel (n = 24), The African-
American Panel (n = 24) and two pedigrees (CEPH/Utah
Pedigree 1331 and CEPH/Amish Pedigree 884). High
quality RNA samples of the Human Total Master panel
II and the Human Adult Normal Tissue Total RNA (39
tissues in total) were purchased from Clontech (Moun-
tain View, USA) and BioCat Gmbh (Heidelberg, Ger-
many) respectively.
Copy number variation analysis
For absolute copy number determination of ABCC6, the
TaqManW Copy Number Assay was used targeting
ABCC6 specifically in intron 11 (Hs03952142_cn; Ap-
plied Biosystems, Foster City, USA). Rnase P, which is
known to be present in two copies in the human gen-
ome, was used as endogenous reference gene (TaqManW
Copy Number Reference Assay Rnase P, Applied Biosys-
tems). The ABCC6 assay (labeled with FAM), the RnaseP
assay (labeled with VIC), sample DNA and 2xTaqMan
Universal PCR Master Mix was combined in 20 μl reac-
tions and ran in quadruplicate on a 7900HT Fast Real-
Time PCR System using standard conditions (Applied
Biosystem). The absolute copy number of ABCC6 was
thereby calculated using CopyCaller™Software v1.0 (Ap-
plied Biosystems).
For pyrosequencing, two sets of PCR primers were
designed to amplify ABCC6, ABCC6P1 and ABCC6P2.
The first set of primers targeted intron 7 of ABCC6 and
ABCC6P1 only, while the other set of primers targeted
exon 2 of all three genes (Table 2 and Figure 1). The
genes were amplified from ~100 ng of genomic DNA in
25 μL reactions using 1 x PyroMark PCR Master Mix, 1
x CoralLoad Concentrate (Qiagen, Venlo, The Nether-
lands) and 0.2 μM primers. Cycling conditions were an
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initial enzyme activation step at 95°C for 15 min and
45 cycles of 94°C for 30 s, 60°C for 30 s, and 72°C for
30 s, and a final extension cycle of 72°C for 10 min.
Twenty micro liter of PCR products were added to 40
μL Binding Buffer (Qiagen), 2 μL streptavidin sepharose
high-performance beads (GE Healthcare, Little Chalfont,
United Kingdom) and 18 μL water and stirred for 5–
10 min at 1400 rpm on a mixer. Single stranded biotiny-
lated templates were isolated using PyroMark Vacuum
Prep WorkStation (Qiagen) and dispensed onto Pyro-
MarkQ24 plate containing 25 μL of 0.3 μM sequencing
primer and Annealing Buffer (Qiagen). The plates were
incubated for 2 min at 80°C and subsequently cooled at
room temperature for at least 5 min. Sequencing was
performed using a PyroMark Q24 instrument with Pyro-
Gold reagents (Qiagen). In the sequencing reaction, one
and one nucleotide is added at the time, and peak
heights are propotional to the amount of nucleotide
molecules incorporated. Therefore, relative copy num-
bers were calculated using ratios of pyrogram peak
heights: ABCC6/(ABCC6+ABCC6P1) =C5/C8 (C5 and
C8 being the peak heights at dispensation 5 and 8, re-
spectively for assay #1) and ABCC6P2/(ABCC6+
ABCC6P1+ABCC6P2) = T8/T6 (T6 and T8 being the
peak heights at dispensation 6 and 8, respectively for
assay # 2, note; reverse sequencing) (Table 2).
The absolute copy number for each allele (ABCC6,
ABCC6P1 and ABCC6P2) was finally deduced from the
TaqManW Copy Number Assay and the two pyrosequen-
cing assays.
Gene expression analysis
cDNA was synthesized from total RNA from 39 tissues
(1 μg) by reverse-transcription using Omniscript RT kit
(Qiagen) in the presence of oligo-dT and random hex-
amer primers (Applied Biosystems) in 20 μL reactions.
Previously, the mRNA expression pattern of ABCC6
and ABCC6P1 in 20 different tissues was described by
our group [7]. In this study, we determined the mRNA
expression pattern of ABCC6 and ABCC6P1 in a total of
39 tissues by RT-qPCR on a 7900HT Fast Real-Time
PCR System (Applied Biosystems). Five of twelve refer-
ence genes were estimated by geNorm [27] to give the
most reliable normalization factors (see [28] for assay
IDs): GAPDH= PGK1 > SDHA >CTBP1 >GOLGA1 . The
expression of ABCC6 and ABCC6P1 was normalized to
these factors for each tissue.
Due to methodological issues, the mRNA expression
pattern of ABCC6P2 was not investigated in our previ-
ous study [7]. In this study, the relative mRNA expres-
sion pattern of ABCC6P2 was analyzed by
pyrosequencing. Primers for mRNA expression were
designed to amplify ABCC6, ABCC6P1 and ABCC6P2
expressed genes (Table 2). The relative transcription of
ABCC6P2 to ABCC6 and ABCC6P1 in the same 39 tis-
sues was quantified using the same equation as
above: ABCC6P2/(ABCC6+ABCC6P1+ABCC6P2) = T8/
T6; Assay #3, Table 2), and by using the expressional
data (RT-qPCR) of ABCC6 and ABCC6P1. All PCR sam-
ples were run in parallels. No parallels varied more than
0.5 quantification cycles in qPCR experiments or 0.1 in
pyrosequencing peak height ratios.
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123456789
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Reverse 5’-Biotin-GAGGGGAAGGGAGAGATTAGC-3’
Sequencing 5’-GCCTGGCCCTGCCGC-3’ GTAGCTGCT
2 ABCC6-ABCC6P1-ABCC6P2 gDNA Forward 5’-Biotin-TCCCATCTACCTCCTCTTCATC-3’ 76
Reverse 5’-ATCTTGGCTTTGAAGAGTGG-3’
Sequencing 5’-TGGCTTTGAAGAGTGG-3’ CGACATCT
3 ABCC6-ABCC6P1-ABCC6P2 cDNA Forward 5’-Biotin-CGGGGCAGGGGGTCTGGAAC-3’ 195
Reverse 5’-ATCTTGGCTTTGAAGAGTGG-3’
Sequencing 5’-TGGCTTTGAAGAGTGG-3’ CGACATCT
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